Timing of nephrology referral: Influence on mortality and morbidity

Roubicek, Christa; Brunet, Philippe; Huiart, Laëtitia; Thirion, Xavier; Leonetti, F.; Dussol, B.; Jaber, Khalil; Andrieu, Daniel; Ramananarivo, P.; Berland, Yvon

doi:10.1053/ajkd.2000.8241

Cited by 156 publications

(126 citation statements)

References 10 publications

Supporting

Mentioning

109

Contrasting

Unclassified

Order By: Relevance

“…The studies reported findings from a wide range of countries: three studies from the UK, 236,237,273 a further four from Europe, 239,251,266,269 three from the USA, 249,277,352 five from Asia, 243,252,253,271,278 one from Australia/New Zealand 230 and one from Brazil. 270 All 17 studies were available in full publication.…”

Section: Resultsmentioning

confidence: 99%

“…Seven studies 230,236,239,271,273,277,352 defined 'late referral' as being less than 3 months between referral and starting dialysis. A definition of less than 16 weeks/4 months was used in two studies, 249,266 while one study 251 determined 'late referral' in relation to GFR. Patients with a GFR < 20 ml/min/1.73 m² at first referral were grouped as 'late referral'.…”

Section: Resultsmentioning

confidence: 99%

“…251 Four of the studies specified in their methods that people with acute renal failure were excluded. 230,239,249,266 …”

Section: Resultsmentioning

confidence: 99%

“…Two further studies reported mortality at 3 and 6 months and were included in the table for completeness. 266,270 The 1-year ACM after initiation of RRT varied substantially between studies, ranging from 2.8% 237 to 27.5% 236 in the early referral group. In late referral groups, 1-year mortality ranged from 7.4% 237 to 39.5%.…”

Section: -Year Mortalitymentioning

confidence: 99%

See 3 more Smart Citations

Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis

Black

Sharma²,

Scotland³

et al. 2010

Health Technol Assess

174

144

View full text Add to dashboard Cite

How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address. Paying by credit cardYou can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume. How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment programmeT he Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care.The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects...

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

“…251 Four of the studies specified in their methods that people with acute renal failure were excluded. 230,239,249,266 …”

Section: Resultsmentioning

confidence: 99%

Section: -Year Mortalitymentioning

confidence: 99%

See 2 more Smart Citations

Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis

Black

Sharma²,

Scotland³

et al. 2010

Health Technol Assess

174

144

View full text Add to dashboard Cite

show abstract

“…They also indicate that in facilities with the practice of early cannulation of AVF (within 4 weeks from their creation) and promptly performed VA surgeries with success in creating VA in older, diabetic women greatly enhance the odds of their patients for using a permanent access rather than TC [153]. In new dialysis patients, early referral to a nephrologist and early patient education strongly predict a successful functioning permanent VA at dialysis initiation and it also seems that the patients have better metabolic and clinical situation at the beginning of HD, lower long-term morbidity and higher survival for the first two years [154][155][156][157][158]. AV fistula is better when used for the first haemodialysis treatment compared to starting haemodialysis with a catheter [55,159,160].…”

Section: Final Remarks and Conclusionmentioning

confidence: 99%